PDCD1 and neoplasm: Although treatment with CBDCA or anti-PD-1 antibodies alone reduced tumor size at Day 24 after implantation (Supplemental Tables 1–3), these two strategies had no therapeutic effects in prolonging the survival (Supplemental Tables 4–6).